We are Tetrabutylammonium hydrogensulfate CAS:32503-27-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests
Chemical Name:Tetrabutylammonium hydrogensulfate
CAS.NO:32503-27-8
Synonyms:Tetrabutylammonium hydrogensulfate
n,n,n-tributyl-1-butanaminiumhydrogen sulfate
Tetrabutyl ammonium bisulfate
Tetra-n-Butylammonium Hydrogen Sulfate
Physical and Chemical Properties:
Melting Point 171-174 °C
Molecular Formula C16H37NO4S
Molecular Weight 339.53400
Exact Mass 339.24400
PSA 85.81000
LogP 5.08900
Specification:
Appearance:White powder
Assay:99%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Displays antibacterial properties due to the presence of the quaternary amine and the counter ion.
Our quaternary ammonium salt series products reach more than 200 kinds, and the product categories cover high-content quaternary ammonium salt (powder, crystal, paste), low-content quaternary ammonium salt (liquid, paste), special quaternary ammonium salt, and quaternary ammonium salt. Alkali, etc., and can provide customized services for related products.
Our main R&D directions are: oilfield chemicals and quaternary ammonium salt downstream products (such as emulsifiers for pesticides, disinfectants for aquatic products, surfactants with special requirements for daily chemicals, etc.) and new innovative structures Surfactant. Therefore, in addition to supplying conventional surfactant products, we can also customize various surfactant products with special requirements according to customer needs to meet the special needs of various industries for surfactants.
Market News:EMA’s human medicines committee (CHMP) has endorsed findings of a review which concluded that there is no evidence Zynteglo causes a blood cancer known as acute myeloid leukaemia (AML). [Pt(C2N2S2)(bis(diphenylphosphino)ethane)] manufacturer.Pfizer said on Wednesday it believes people need the additional dose to keep protection against the coronavirus high. The company says it could apply for U.S. emergency authorization for booster shots as early as August. read more ethyl 2,2-bis(methylthio)-1-cyclobutanecarboxylate supplier.In addition, AstraZeneca is exploring the potential of anifrolumab in a variety of diseases where type I interferon plays a key role, including lupus nephritis, cutaneous lupus erythematosus and myositis. 1-(anthracen-9-yl)ethan-1-one O-benzoyl oxime producer.
